This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Novartis Ag, Hoffmann-La Roche Inc.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Claudia Mueller: Innovator in Antibody Formulation
Introduction
Claudia Mueller is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the formulation of antibodies. With a total of 4 patents to her name, her work focuses on improving the delivery mechanisms of therapeutic antibodies.
Latest Patents
One of her latest patents is the Anti-CD40 antibody formulation delivery device. This innovation allows Anti-CD40 antibodies to be formulated as either a lyophilisate or a liquid formulation. The lyophilisates can be reconstituted to create a solution with a high concentration of the antibody active ingredient, ensuring effective delivery to patients without high levels of antibody aggregation. The lyophilisate can be reconstituted with an aqueous reconstituent to provide an aqueous composition with an antibody concentration of at least 50 mg/ml. Additionally, the lyophilisate or aqueous pharmaceutical composition may include various components such as sugars, buffering agents, surfactants, and free amino acids.
Another significant patent by Claudia is the Anti-CD40 antibody formulation, which shares similar characteristics with her delivery device. This formulation also emphasizes the importance of maintaining high concentrations of the antibody while minimizing aggregation, thereby enhancing the therapeutic efficacy of the treatment.
Career Highlights
Claudia has worked with leading pharmaceutical companies, including Novartis AG and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in antibody formulation.
Collaborations
Throughout her career, Claudia has collaborated with notable professionals in her field, including Matthias Willmann and Christian Freichel. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Claudia Mueller is a trailblazer in the field of antibody formulation, with a focus on enhancing the delivery of therapeutic agents. Her innovative patents and collaborations with leading companies and professionals underscore her impact on biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile